Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: Design of a randomized controlled trial

BMC Neurology

Volumn 11, Issue , 2011, Pages

  de Kinderen, Reina J A ^a,b   Lambrechts, Danielle A J E ^b   Postulart, Debby ^b   Kessels, Alfons G H ^c   Hendriksen, Jos G M ^b,c   Aldenkamp, Albert P ^a,b,c   Evers, Silvia M A A ^a   Majoie, Marian H J M ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COGNITION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; EMOTION; FOLLOW UP; HUMAN; INFANT; INTRACTABLE EPILEPSY; KETOGENIC DIET; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEIZURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIET THERAPY; ECONOMICS; EPILEPSY; HOSPITALIZATION; METHODOLOGY; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EPILEPSY; HUMANS; INFANT; KETOGENIC DIET; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 78951473774     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-10     Document Type: Article

References (49)

1. Fisher RS, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46(4):470-2. 10.1111/j.0013-9580.2005.66104.x, 15816939.
2. Strzelczyk A, et al. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008, 26(6):463-76. 10.2165/00019053-200826060-00002, 18489198.
3. Leonardi M, Ustun TB. The global burden of epilepsy. Epilepsia 2002, 43(Suppl 6):21-5. 10.1046/j.1528-1157.43.s.6.11.x, 12190974.
4. Forsgren L, et al. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005, 12(4):245-53. 10.1111/j.1468-1331.2004.00992.x, 15804240.
5. Pugliatti M, et al. Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 2007, 48(12):2224-33.
6. Poos MJJC, Smit JM, Groen J, Kommer GJ, SLobbe LCJ. Kosten van ziekten in Nederland 2005. RIVM 2008,
7. Hoeymans N, Melse JM, Schoenmaker CG. Gezondheid en determinanten. Deelrapport van de Volksgezondheid Toekomst Verkenning 2010 Van gezond naar beter. RIVM-rapport nr. 270061006 2010,
8. Kossoff EH, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009, 50(2):304-17. 10.1111/j.1528-1167.2008.01765.x, 18823325.
9. Freeman J, et al. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 2006, 68(2):145-80. 10.1016/j.eplepsyres.2005.10.003, 16523530.
10. Kossoff EH, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006, 47(2):421-4. 10.1111/j.1528-1167.2006.00438.x, 16499770.
11. Zupec-Kania BA, Spellman E. An overview of the ketogenic diet for pediatric epilepsy. Nutr Clin Pract 2008, 23(6):589-96. 10.1177/0884533608326138, 19033218.
12. Caraballo RH, et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005, 46(9):1539-44. 10.1111/j.1528-1167.2005.05705.x, 16146451.
13. Coppola G, et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res 2002, 48(3):221-7. 10.1016/S0920-1211(01)00315-1, 11904241.
14. Freeman JM, et al. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998, 102(6):1358-63. 10.1542/peds.102.6.1358, 9832569.
15. Kang HC, et al. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 2005, 46(2):272-9. 10.1111/j.0013-9580.2005.48504.x, 15679508.
16. Kankirawatana P, et al. Ketogenic diet: an alternative treatment for refractory epilepsy in children. J Med Assoc Thai 2001, 84(7):1027-32.
17. Kossoff EH, et al. Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002, 109(5):780-3. 10.1542/peds.109.5.780, 11986436.
18. Kossoff EH, et al. Tuberous sclerosis complex and the ketogenic diet. Epilepsia 2005, 46(10):1684-6. 10.1111/j.1528-1167.2005.00266.x, 16190943.
19. Maydell BV, et al. Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr Neurol 2001, 25(3):208-12. 10.1016/S0887-8994(01)00310-1, 11587874.
20. Vining EP, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 1998, 55(11):1433-7. 10.1001/archneur.55.11.1433, 9823827.
21. Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol 2006, 35(1):1-5. 10.1016/j.pediatrneurol.2006.01.005, 16814077.
22. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics 2000, 105(4):E46. 10.1542/peds.105.4.e46, 10742367.
23. Levy R, Cooper P. Ketogenic diet for epilepsy. Cochrane Database Syst Rev 2003, (3):CD001903.
24. Sinha SR, Kossoff EH. The ketogenic diet. Neurologist 2005, 11(3):161-70. 10.1097/01.nrl.0000160818.58821.d2, 15860138.
25. Neal EG, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008, 7(6):500-6. 10.1016/S1474-4422(08)70092-9, 18456557.
26. O'Donoghue MF, Duncan JS, Sander JW. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia 1996, 37(6):563-71.
27. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test-III-NL, Nederlandse versie door Liesbeth Schlichting. 2005, Harcourt Assessment B.V., Amsterdam.
28. Beery K. The Beery-Buktenica Developmental Test of Visual-Motor Integration: VMI with Supplemental Developmental Test of Visual Perception and Motor Coordination: Administration, Scoring and Teaching Manual. 1997, Parsippany, NJ: Modern Curriculum Press.
29. Alpherts WC, Aldenkamp AP. Computerized neuropsychological assessment of cognitive functioning in children with epilepsy. Epilepsia 1990, 31(Suppl 4):S35-40. 10.1111/j.1528-1157.1990.tb05868.x, 2279481.
30. Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children (K-ABC). 1983, Publishing, Circle Pines.
31. Scholte EM, van der Ploeg JD. Handleiding Sociaal-Emotionele Vragenlijst (SEV). 2007, Houten: Bohn Stafleu van Loghum.
32. Berkel A, et al. Handleiding voor het gebruik van de SDQ binnen de jeugdgezondheidszorg. Vragenlijst voor het signaleren van psychosociale problemen bij kinderen van 7-12 jaar. Zutphen: Markant congressen 2006,
33. MC Nair DM, Lorr M, Droppleman L. Profile of Mood States: Manual 1971, San Diego, CA: Educational and Industrial Testing Service.
34. Walker DK, et al. Assessing psychosocial adjustment of children with chronic illnesses: a review of the technical properties of PARS III. J Dev Behav Pediatr 1990, 11(3):116-21. 10.1097/00004703-199006000-00004, 2365832.
35. Hendriksen JG, et al. Psychosocial adjustment in males with Duchenne muscular dystrophy: psychometric properties and clinical utility of a parent-report questionnaire. J Pediatr Psychol 2009, 34(1):69-78. 10.1093/jpepsy/jsn067, 18650207.
36. Carpay HA, et al. Disability due to restrictions in childhood epilepsy. Dev Med Child Neurol 1997, 39(8):521-6. 10.1111/j.1469-8749.1997.tb07480.x, 9295847.
37. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 2000, 31(2):73-86. 10.1016/S0005-7916(00)00012-4, 11132119.
38. EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990, 16(3):199-208. 10.1016/0168-8510(90)90421-9, 10109801.
39. Fekkes M, et al. Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res 2000, 9(8):961-72. 10.1023/A:1008981603178, 11284215.
40. Vogels T, Verrips GH, Koopman HM. TACQOL manual. Parent Form and Child Form 2000, Leiden: Leiden Center for Child Health and Pediatrics LUMC-TNO.
41. Goossens ME, et al. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000, 53(7):688-95. 10.1016/S0895-4356(99)00177-8, 10941945.
42. Oostenbrink JB, et al. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekeringen 2004,
43. Koopmanschap MA. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoecon Outcomes Res 2005, 5(1):23-8. 10.1586/14737167.5.1.23, 19807557.
44. Dolan P, et al. The time trade-off method: results from a general population study. Health Econ 1996, 5(2):141-54. 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N, 8733106.
45. Lamers LM, et al. Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd 2005, 149(28):1574-8.
46. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005, 14(5):487-96. 10.1002/hec.944, 15497198.
47. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000, 19(23):3219-36. 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P, 11113956.
48. Ramsey S, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005, 8(5):521-33. 10.1111/j.1524-4733.2005.00045.x, 16176491.
49. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997, 6(4):327-40. 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W, 9285227.